David Wu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- Genomics, phytochemicals, and oxidative stress
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Nutrition, Genetics, and Disease 2
- Co-authors
- Lewis C. Cantley (4 shared papers)John M. Asara (2 shared papers)Pei-Hsuan Chen (1 shared paper)Kenneth E. Huffman (1 shared paper)Ignacio I. Wistuba (1 shared paper)Gina M. DeNicola (1 shared paper)Hao Tang (1 shared paper)Jessica Sudderth (1 shared paper)
- Journals
- Integrative Cancer Therapies (2 papers)Applied Mathematical Finance (1 paper)Nature Genetics (1 paper)Blood (1 paper)The American Surgeon (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
David Wu
21 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 510
- Molecular Biology 1.1k
- Biochemistry 76
- Genetics 105
- Physiology 239
Countries citing papers authored by David Wu
This map shows the geographic impact of David Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wu more than expected).
Fields of papers citing papers by David Wu
This network shows the impact of papers produced by David Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wu. The network helps show where David Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside David Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NRF2 regulates serine biosynthesis in non–small cell lung cancer Hit paper breakdown → | 2015 | 560 |
| 2 | Suppression of insulin feedback enhances the efficacy of PI3K inhibitors Hit paper breakdown → | 2018 | 481 |
| 3 | 2012 | 127 | |
| 4 | 2018 | 85 | |
| 5 | 2008 | 78 | |
| 6 | 2013 | 50 | |
| 7 | 2018 | 39 | |
| 8 | 2017 | 35 | |
| 9 | 1997 | 26 | |
| 10 | 2023 | 20 | |
| 11 | 1999 | 20 | |
| 12 | 2017 | 9 | |
| 13 | 2014 | 7 | |
| 14 | 2023 | 3 | |
| 15 | 2017 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2006 | 2 | |
| 18 | 2015 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 1 |
About David Wu
David Wu is a scholar working on Molecular Biology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Finance, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Analytical Chemistry and Chromatography (2 papers), Epigenetics and DNA Methylation (2 papers), Stochastic processes and financial applications (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), RNA modifications and cancer (2 papers) and Nutrition, Genetics, and Disease (2 papers). The work is most often cited by research in Cancer Research (510 citations), Molecular Biology (1.1k citations), Biochemistry (76 citations), Genetics (105 citations) and Physiology (239 citations). David Wu has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Lewis C. Cantley, John M. Asara, Pei-Hsuan Chen, Kenneth E. Huffman, Ignacio I. Wistuba, Gina M. DeNicola, Hao Tang, Jessica Sudderth, Ralph J. DeBerardinis and Edouard Mullarky. Their work appears in journals such as Integrative Cancer Therapies, Applied Mathematical Finance, Nature Genetics, Blood and The American Surgeon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.